1
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lee Y, Ahn C, Han J, et al: The nuclear
RNase III Drosha initiates microRNA processing. Nature.
425:415–419. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kong W, Zhao JJ, He L and Cheng JQ:
Strategies for profiling microRNA expression. J Cell Physiol.
218:22–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hutvágner G, McLachlan J, Pasquinelli AE,
Bálint E, Tuschl T and Zamore PD: A cellular function for the
RNA-interference enzyme Dicer in the maturation of the let-7 small
temporal RNA. Science. 293:834–838. 2001.PubMed/NCBI
|
5
|
Grishok A, Pasquinelli AE, Conte D, et al:
Genes and mechanisms related to RNA interference regulate
expression of the small temporal RNAs that control C. elegans
developmental timing. Cell. 106:23–34. 2001. View Article : Google Scholar : PubMed/NCBI
|
6
|
Schwarz DS, Hutvágner G, Du T, Xu Z,
Aronin N and Zamore PD: Asymmetry in the assembly of the RNAi
enzyme complex. Cell. 115:199–208. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008.PubMed/NCBI
|
8
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:E852005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bartel DP: MicroRNAs genomics, biogenesis,
mechanism, and function. Cell. 116:281–297. 2004.PubMed/NCBI
|
10
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Crawford M, Brawner E, Batte K, et al:
MicroRNA-126 inhibits invasion in nonsmall cell lung carcinoma cell
lines. Biochem Biophys Res Commun. 373:607–612. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Tavazoie SF, Alarcón C, Oskarsson T, et
al: Endogenous human microRNAs that suppress breast cancer
metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Valastyan S, Reinhardt F, Benaich N, et
al: A pleiotropically acting microRNA miR-31, inhibits breast
cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kong W, Yang H, He L, et al: MicroRNA-155
is regulated by the transforming growth factor beta/ Smad pathway
and contributes to epithelial cell plasticity by targeting RhoA.
Mol Cell Biol. 28:6773–6784. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar
|
18
|
Gabriely G, Wurdinger T, Kesari S, et al:
MicroRNA 21 promotes glioma invasion by targeting matrix
metalloproteinase regulators. Mol Cell Biol. 28:5369–5380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang J, Mani SA and Weinberg RA: Exploring
a new twist on tumor metastasis. Cancer Res. 66:4549–4552. 2006.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Lodygin D, Tarasov V, Epanchintsev A, et
al: Inactivation of miR-34a by aberrant CpG methylation in multiple
types of cancer. Cell Cycle. 7:2591–2600. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bommer GT, Gerin I, Feng Y, et al:
p53-mediated activation of miRNA34 candidate tumor-suppressor
genes. Curr Biol. 17:1298–1307. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
He L, He X, Lim LP, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Tarasov V, Jung P, Verdoodt B, et al:
Differential regulation of microRNAs by p53 revealed by massively
parallel sequencing: miR-34a is a p53 target that induces apoptosis
and G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Cohen SM, Brennecke J and Stark A:
Denoising feedback loops by thresholding-a new role for microRNAs.
Genes Dev. 20:2769–2772. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Naran S, Zhang X and Hughes S J:
Inhibition of HGF/MET as therapy for malignancy. Expert Opin Ther
Targets. 13:569–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Furlan A, Stagni V, Hussain A, et al: Abl
interconnects oncogenic Met and p53 core pathways in cancer cells.
Cell Death Differ. 18:1608–1616. 2011. View Article : Google Scholar : PubMed/NCBI
|